PharmaShots | Incisive News in 3 Shots

Subscribe Now

AMD patients

Alteogen Reports Completion of P-I Study of ALT-L9 (biosimilar- aflibercept) in Korea

Alteogen Reports Completion of P-I Study of ALT-L9 (biosimilar- aflibercept) in Korea

March 9, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us